Anish Bhatnagar - Jan 28, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
President and Chief Executive Officer, Director
Signature
/s/ Anish Bhatnagar
Stock symbol
SLNO
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 03:08 PM
Previous filing
Jan 25, 2022
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +610K $0.00 610K Jan 28, 2022 Common Stock 610K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of Vesting Commencement Date (January 1, 2022), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person continuing to be a Service Provider through each such date.

Remarks:

President and Chief Executive Officer